Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Aug
10
2023
TRI PFAS Obligations May Expand Considerably CMBG3 Law
Aug
10
2023
FDA Draft Guidance Provides Further Details on New Cosmetic Product Facility Registration and Product Listing Requirements ArentFox Schiff LLP
Aug
10
2023
Modernization of Cosmetics Regulation Act of 2022 ArentFox Schiff LLP
Aug
10
2023
TSCA Section 21 Citizen Petition Seeks Prohibition of 6PPD in Tires Bergeson & Campbell, P.C.
Aug
10
2023
Cosmetic Product Registration and Listing Under MoCRA Comes Closer Beveridge & Diamond PC
Aug
9
2023
FDA Issues Final Administrative Actions on Partially Hydrogenated Oils in Foods Keller and Heckman LLP
Aug
9
2023
FDA Publishes Draft Guidance on Cosmetic Product Facility Registration and Cosmetic Product Listing Mintz
Aug
9
2023
PFAS MDL Settlements Face Additional Questions CMBG3 Law
Aug
8
2023
EUON Publishes Study Identifying Status of Animal-Free Test Methods for Use on Nanomaterials Bergeson & Campbell, P.C.
Aug
8
2023
Third Party Administrator & Pharmacy Benefit Manager 2023 Newsletter Polsinelli PC
Aug
8
2023
FDA Issues Draft Guidance on Registration of Cosmetic Product Facilities and Products Keller and Heckman LLP
Aug
8
2023
The FTC Finalizes Changes to Endorsement Guides Epstein Becker & Green, P.C.
Aug
8
2023
Alabama Medical Cannabis Update: August 10 Appears to Be the Day Bradley Arant Boult Cummings LLP
Aug
8
2023
DEA: Potential New Telemedicine Special Registration for Controlled Substances Prescribing to be Discussed in Special Listening Sessions Foley & Lardner LLP
Aug
7
2023
A Watched Pot Never Boils: SAFE Banking on the Backburner Again Bradley Arant Boult Cummings LLP
Aug
7
2023
California Judge Certifies Class in Bigelow Tea False Advertising Lawsuit Keller and Heckman LLP
Aug
4
2023
FDA Announces Public Meeting to Modernize Recalls Keller and Heckman LLP
Aug
4
2023
Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy McDermott Will & Emery
Aug
3
2023
OECD Publishes Consensus Document on Environmental Considerations for the Release of Transgenic Plants Bergeson & Campbell, P.C.
Aug
3
2023
Good News, Bad News: Congress Wants to Help the Hemp Industry Bradley Arant Boult Cummings LLP
Aug
3
2023
The Secret to Success: Protecting Your Cannabis Trade Secrets Bradley Arant Boult Cummings LLP
Aug
2
2023
EC Committee Updates Guidance on the Safety Assessment of Nanomaterials in Cosmetics Bergeson & Campbell, P.C.
Aug
2
2023
AAFCO Approves New Model Pet Food and Specialty Pet Food Regulations for Pet Food Packaging Keller and Heckman LLP
Aug
2
2023
FDA Warns “Natural” Birth Control Company: Three Takeaways from the NOV Letter Mintz
Aug
1
2023
BETO Will Host Bioenergy Cybersecurity Workshop on September 11, 2023 Bergeson & Campbell, P.C.
Aug
1
2023
Lawsuit Against Starbucks Dismissed; Sanctions Against Plaintiff’s Attorney Considered Keller and Heckman LLP
Aug
1
2023
Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls Epstein Becker & Green, P.C.
Aug
1
2023
Cancer Moonshot Initiative Adds Precision Surgery Effort Foley & Lardner LLP
Aug
1
2023
EPA Adds Nine PFAS Chemicals to The Toxics Release Inventory Reporting List Babst, Calland, Clements & Zomnir, P.C.
Aug
1
2023
Triaging Health Risks in the Cosmetic World: FDA Says Let’s Start with Tattoo Inks Polsinelli PC
Aug
1
2023
FDA’s LDT Proposed Rule Heads to the White House Epstein Becker & Green, P.C.
Aug
1
2023
Podcast: Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now? – Diagnosing Health Care [Podcast] Epstein Becker & Green, P.C.
Aug
1
2023
Washington State Proposes Sweeping Changes to Key Greenhouse Gas Regulation Beveridge & Diamond PC
Jul
31
2023
UCB, Inc. v. Actavis Laboratories UT, Inc. No. 2021-1924, (Fed. Cir. Apr. 12, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jul
31
2023
Proposed Class Action Dismissed Over Lack of Standing Keller and Heckman LLP
Jul
31
2023
The 2024 Proposed Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know ArentFox Schiff LLP
Jul
31
2023
Bipartisan Group of Representatives Calls on EPA to Assess the Risks of PFAS in Fluorinated Containers Bergeson & Campbell, P.C.
Jul
31
2023
APHIS 2022 Impact Report Includes Summary of Biotechnology Activities Bergeson & Campbell, P.C.
Jul
28
2023
Will Mississippi’s List of Qualifying Conditions for Medical Cannabis Soon Be Expanded? Bradley Arant Boult Cummings LLP
Jul
28
2023
Amendment to House Bill Threatens Funding of Organic Standards Keller and Heckman LLP
Jul
27
2023
CMS Proposes Changes to Medicare Provider Enrollment Rules Polsinelli PC
Jul
27
2023
New Medicare Marketing Definition Squire Patton Boggs (US) LLP
Jul
27
2023
CMS Proposes Remedy for 340B-Acquired Drug Payment Policy for CY 2018-2022 Foley & Lardner LLP
Jul
27
2023
FDA Maintains Focus on “Intended Use” for Software-Enabled Medical Devices Sheppard, Mullin, Richter & Hampton LLP
Jul
27
2023
FDA Denies Request to Reconsider Petition on Phthalates in Food Packaging Keller and Heckman LLP
Jul
26
2023
Bipartisan Legislation Would Strengthen USDA’s BioPreferred Program Bergeson & Campbell, P.C.
Jul
26
2023
July 2023 EU’s New HBER and Horizontal Guidelines: Main Changes Greenberg Traurig, LLP
Jul
25
2023
First Nonprescription Birth Control Pill Approved for Marketing by FDA: A Milestone for Reproductive Health Mintz
Jul
25
2023
The Netherlands Provides Taste Testing of Cell-Cultivated Meat and Seafood Keller and Heckman LLP
Jul
25
2023
Real Estate Beneficial Ownership Regulatory Alert: Complying with Foreign Ownership Reporting Requirements in US Real Estate K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins